FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| epinephrine | Epinephrine 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | Gland Pharma Limited | Sep 22, 2026 | 68083-699 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | REMEDYREPACK INC. | Sep 22, 2026 | 70518-4760 |
| Trazodone Hydrochloride | Trazodone hydrochloride 100 mg/1 | TabletOral | Northwind Health Company, LLC | Sep 22, 2026 | 82868-116 |
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | Cipla USA Inc. | Sep 21, 2026 | 69097-292 |
| Acetaminophen | Acetaminophen 10 mg/mL | Injection, SolutionIntravenous | Somerset Therapeutics, LLC | Sep 21, 2026 | 70069-871 |
| Amoxicillin And Clavulanate Potassium | Amoxicillin 875 mg/1; Clavulanate potassium 125 mg/1 | Tablet, CoatedOral | REMEDYREPACK INC. | Sep 21, 2026 | 70518-4758 |
| Cefixime | Cefixime 400 mg/1 | CapsuleOral | REMEDYREPACK INC. | Sep 21, 2026 | 70518-4759 |
| Ziprasidone Mesylate 20 mg/mLziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | Armas Pharmaceuticals Inc. | Sep 21, 2026 | 72485-430 |
| Chlorthalidone | Chlorthalidone 25 mg/1 | TabletOral | Ipca Laboratories Limited | Sep 21, 2026 | 83980-061 |
| Chlorthalidone | Chlorthalidone 50 mg/1 | TabletOral | Ipca Laboratories Limited | Sep 21, 2026 | 83980-062 |
| Aminocaproic Acid | Aminocaproic acid 500 mg/1 | TabletOral | RISING PHARMA HOLDINGS, INC. | Sep 20, 2026 | 16571-326 |
| Aminocaproic Acid | Aminocaproic acid 1000 mg/1 | TabletOral | RISING PHARMA HOLDINGS, INC. | Sep 20, 2026 | 16571-327 |
| Tacrolimus | Tacrolimus .5 mg/1 | CapsuleOral | AvPAK | Sep 20, 2026 | 50268-736 |
| Tacrolimus | Tacrolimus 1 mg/1 | CapsuleOral | AvPAK | Sep 20, 2026 | 50268-737 |
| Rocuronium Bromide | Rocuronium bromide 50 mg/5mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | Sep 18, 2026 | 43066-507 |
| Rocuronium Bromide | Rocuronium bromide 100 mg/10mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | Sep 18, 2026 | 43066-509 |
| Riociguat | Riociguat .5 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc | Sep 18, 2026 | 70710-2156 |
| Riociguat | Riociguat 1 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc | Sep 18, 2026 | 70710-2157 |
| Riociguat | Riociguat 1.5 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc | Sep 18, 2026 | 70710-2158 |
| Riociguat | Riociguat 2 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc | Sep 18, 2026 | 70710-2159 |
| Riociguat | Riociguat 2.5 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc | Sep 18, 2026 | 70710-2160 |
| Ranitidine | Ranitidine hydrochloride 150 mg/1 | TabletOral | Atland Pharmaceuticals, LLC | Sep 18, 2026 | 71993-314 |
| Ranitidine | Ranitidine hydrochloride 300 mg/1 | TabletOral | Atland Pharmaceuticals, LLC | Sep 18, 2026 | 71993-315 |
| Diclofenac Potassium | Diclofenac potassium 75 mg/1 | Tablet, CoatedOral | Advagen Pharma Ltd | Sep 18, 2026 | 72888-203 |
| Eltrombopag | Eltrombopag olamine 50 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | Sep 17, 2026 | 0480-2600 |